149 related articles for article (PubMed ID: 17558446)
1. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
[TBL] [Abstract][Full Text] [Related]
2. Insights into binding modes of 5-HT2c receptor antagonists with ligand-based and receptor-based methods.
Lu C; Jin F; Li C; Li W; Liu G; Tang Y
J Mol Model; 2011 Oct; 17(10):2513-23. PubMed ID: 21203788
[TBL] [Abstract][Full Text] [Related]
3. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
[TBL] [Abstract][Full Text] [Related]
4. The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.
Bray JK; Goddard WA
J Mol Graph Model; 2008 Aug; 27(1):66-81. PubMed ID: 18499489
[TBL] [Abstract][Full Text] [Related]
5. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
[TBL] [Abstract][Full Text] [Related]
6. 5-HT₂c receptor selectivity and structure-activity relationship of N-methyl-N-(1-methylpiperidin-4-yl)benzenesulfonamide analogs.
Jang JW; Baek JS; Choi GD; Park WK; Cho YS; Baek DJ; Pae AN
Bioorg Med Chem Lett; 2012 Jan; 22(1):347-52. PubMed ID: 22153942
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists.
Ivanov AA; Baskin II; Palyulin VA; Piccagli L; Baraldi PG; Zefirov NS
J Med Chem; 2005 Nov; 48(22):6813-20. PubMed ID: 16250640
[TBL] [Abstract][Full Text] [Related]
8. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
Ahmed A; Choo H; Cho YS; Park WK; Pae AN
Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
12. Prediction of 5-HT3 receptor agonist-binding residues using homology modeling.
Reeves DC; Sayed MF; Chau PL; Price KL; Lummis SC
Biophys J; 2003 Apr; 84(4):2338-44. PubMed ID: 12668442
[TBL] [Abstract][Full Text] [Related]
13. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.
Jang JW; Kim MS; Cho YS; Cho AE; Pae AN
J Mol Graph Model; 2012 Sep; 38():342-53. PubMed ID: 23085173
[TBL] [Abstract][Full Text] [Related]
14. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
15. The influence of 5-HT(2A) activity on a 5-HT(2C) specific in vivo assay used for early identification of multiple acting SERT and 5-HT(2C) receptor ligands.
Éliás O; Nógrádi K; Domány G; Szakács Z; Kóti J; Szántay C; Tarcsay Á; Keserű GM; Gere A; Kiss B; Kurkó D; Kolok S; Némethy Z; Kapui Z; Hellinger É; Vastag M; Sághy K; Kedves R; Gyertyán I
Bioorg Med Chem Lett; 2016 Feb; 26(3):914-920. PubMed ID: 26748694
[TBL] [Abstract][Full Text] [Related]
16. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
Cheng J; Kozikowski AP
ChemMedChem; 2015 Dec; 10(12):1963-7. PubMed ID: 26507582
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation.
Shahlaei M; Madadkar-Sobhani A; Mahnam K; Fassihi A; Saghaie L; Mansourian M
Biochim Biophys Acta; 2011 Mar; 1808(3):802-17. PubMed ID: 21167131
[TBL] [Abstract][Full Text] [Related]
18. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
Gadhe CG; Balupuri A; Cho SJ
J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
[TBL] [Abstract][Full Text] [Related]
19. Application of an Integrated GPCR SAR-Modeling Platform To Explain the Activation Selectivity of Human 5-HT2C over 5-HT2B.
Heifetz A; Storer RI; McMurray G; James T; Morao I; Aldeghi M; Bodkin MJ; Biggin PC
ACS Chem Biol; 2016 May; 11(5):1372-82. PubMed ID: 26900768
[TBL] [Abstract][Full Text] [Related]
20. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Berg KA; Cropper JD; Niswender CM; Sanders-Bush E; Emeson RB; Clarke WP
Br J Pharmacol; 2001 Sep; 134(2):386-92. PubMed ID: 11564657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
